Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. administers 293.7 million doses of COVID-19 vaccines - CDC

Published 05/29/2021, 03:19 PM
Updated 05/29/2021, 03:20 PM
© Reuters. FILE PHOTO: A large vaccination site is shown as people with preexisting health conditions are granted access to a vaccination during the outbreak of the coronavirus disease (COVID-19) in Inglewood, California, U.S., March 15, 2021. REUTERS/Mike Blake

(Reuters) - The United States had administered 293,705,050 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 366,314,625 doses, the U.S. Centers for Disease Control and Prevention said.

Those figures are up from the 292,099,778 vaccine doses the CDC said had been administered by May 28, out of 362,375,765 doses delivered.

The agency said 167,157,043 people or about half of all Americans had received at least one dose, while 134,418,748 people had been fully vaccinated as of Saturday.

The CDC tally includes two-dose vaccines from Moderna (NASDAQ:MRNA) Inc and Pfizer/BioNTech, as well as Johnson & Johnson (NYSE:JNJ)'s one-shot vaccine as of 6 a.m. EDT on Saturday.

Latest comments

No-body-cures.
incredible the disparity between trumps last 100 days and Biden's first 100 days.
And how many gallons of bleach??
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.